Enhanced CRP serum levels in HT patients are probably due to the impact of IL-6 on tumor necrosis factor α (TNF-α) and IL-1, as well as the reduction of the CRP clearance rate due to the decreased metabolic rate in these patients [50, 51]. This evidence concerns the gene CRP and hematocrit.